Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis
Andus, Tilo, Kocjan, Andreas, Müser, Moritz, Baranovsky, Andrey, Mikhailova, Tatyana L., Zvyagintseva, Tatyana D., Dorofeyev, Andrey E., Lozynskyy, Yurii S., Cascorbi, Ingolf, Stolte, Manfred, Vieth, Michael, Dilger, Karin, Mohrbacher, Ralf, Greinwald, Roland
Published in Inflammatory bowel diseases (01.11.2010)
Published in Inflammatory bowel diseases (01.11.2010)
Get full text
Journal Article
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis
Kruis, Wolfgang, Neshta, Viacheslav, Pesegova, Marina, Alekseeva, Olga, Andreev, Pavel, Datsenko, Oleksii, Levchenko, Olena, Abdulkhakov, Sayar, Lozynskyy, Yuriy, Mostovoy, Yuriy, Soloviev, Konstantin, Dorofeyev, Andrey E., Vieth, Michael, Stiess, Michael, Greinwald, Roland, Mohrbacher, Ralf, Siegmund, Britta
Published in Clinical gastroenterology and hepatology (01.01.2019)
Published in Clinical gastroenterology and hepatology (01.01.2019)
Get full text
Journal Article
Sa1794 Recurrence Rate After Uncomplicated Diverticulitis and Evaluation of Risk Factors for Relapses After an Attack of Uncomplicated Diverticulitis
Kruis, Wolfgang, Mohrbacher, Ralf, Greinwald, Roland, Banai, János, Bunganic, Ivan, Dorofeyev, Andrey E, Kardalinos, Vassilios, Spiller, Robin C
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Get full text
Journal Article
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
Gross, Volker, Bunganic, Ivan, Belousova, Elena A., Mikhailova, Tatyana L., Kupcinskas, Limas, Kiudelis, Gediminas, Tulassay, Zsolt, Gabalec, Libor, Dorofeyev, Andrey E., Derova, Jelena, Dilger, Karin, Greinwald, Roland, Mueller, Ralph
Published in Journal of Crohn's and colitis (01.04.2011)
Published in Journal of Crohn's and colitis (01.04.2011)
Get full text
Journal Article
Sa1217 Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study
Dignass, Axel U, Stoynov, Simeon, Dorofeyev, Andrey E, Grigorieva, Galina A, Tomsova, Eva, Altorjay, István, Tuculanu, Daniel, Bunganic, Ivan, Pokrotnieks, Juris, Kupcinskas, Limas, Greinwald, Roland, Mueller, Ralph
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2013)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2013)
Get full text
Journal Article
1052 Daily Mesalamine Fails to Prevent Recurrent Diverticulitis in a Large Placebo Controlled Multicenter Trial
Kruis, Wolfgang, Kardalinos, Vassilios, Curtin, Austin, Dorofeyev, Andrey E, Zakko, Salam F, Wölkner, Jens, Alonso, Manuel M. Diez, Peeters, Harald, Koutroubakis, Ioannis E, Talley, Nicholas J, Dilger, Karin, Mohrbacher, Ralf, Greinwald, Roland
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2014)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2014)
Get full text
Journal Article
Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
Dignass, Axel, Stoynov, Simeon, Dorofeyev, Andrey E., Grigorieva, Galina A., Tomsová, Eva, Altorjay, István, Tuculanu, Daniel, Bunganič, Ivan, Pokrotnieks, Juris, Kupčinskas, Limas, Dilger, Karin, Greinwald, Roland, Mueller, Ralph
Published in Journal of Crohn's and colitis (01.09.2014)
Published in Journal of Crohn's and colitis (01.09.2014)
Get full text
Journal Article